Skip to main content

Novel B-lymphocyte-deleting agents for the treatment of autoimmune diseases: induction of the mitochondrial pathway of apoptosis

Background

To develop new approaches for the targeted deletion of pathogenic autoimmune B lymphocytes, we have studied a bacterial product, protein A of Staphylococcus aureus (SpA). We have previously discovered that SpA has the properties of a B-cell superantigen, enabling interactions with conserved variable region framework subdomains of the antigen receptors of lymphocytes rather than the complementarity determining region involved in the binding of conventional antigens [1]. Exposure to SpA can induce immune tolerance affecting a supraclonal set of lymphocytes [2].

Objective

To evaluate the outcome of in vivo SpA treatment.

Results

Within hours, a sequence of events is initiated only in targeted B cells, with rapid downregulation of B-cell antigen receptor and the coreceptors CD19 and CD21, the induction of an activation phenotype, and limited rounds of proliferation. Massive B-cell-specific apoptosis then occurs through a process heralded by the dissipation of mitochondrial membrane potential, followed later by the induction of the caspase pathway and DNA fragmentation. Post exposure, B-cell apoptotic bodies are deposited in the spleen, the lymph nodes and Peyers patches. While in vivo apoptosis does not require a death receptor, such as Fas, recent studies have demonstrated that apoptosis is linked to an induced imbalance in the members of the Bcl-2 family. By microfluorimetry and deconvoluted confocal microscopy, SpA induced a rapid depletion of Bcl-XL. There was also increased expression and translocation of a pro-apoptotic BH3-only member, which can form heterodimers resulting in Bax/Bak-mediated death.

References

  1. Graille M, et al: Proc Natl Acad Sci USA. 2000, 97: 5399-5404. 10.1073/pnas.97.10.5399.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  2. Silverman GJ, et al: J Exp Med. 2000, 192: 87-98. 10.1084/jem.192.1.87.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Silverman, G., Goodyear, C. Novel B-lymphocyte-deleting agents for the treatment of autoimmune diseases: induction of the mitochondrial pathway of apoptosis. Arthritis Res Ther 5, 97 (2003). https://doi.org/10.1186/ar898

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/ar898

Keywords

  • Mitochondrial Membrane Potential
  • Bacterial Product
  • Mitochondrial Pathway
  • Antigen Receptor
  • Post Exposure